Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Flora S, Siami"'
Autor:
Alik Farber, Matthew T. Menard, Michael S. Conte, John A. Kaufman, Richard J. Powell, Niteesh K. Choudhry, Taye H. Hamza, Susan F. Assmann, Mark A. Creager, Mark J. Cziraky, Michael D. Dake, Michael R. Jaff, Diane Reid, Flora S. Siami, George Sopko, Christopher J. White, Max van Over, Michael B. Strong, Maria F. Villarreal, Michelle McKean, Ezana Azene, Amir Azarbal, Andrew Barleben, David K. Chew, Leonardo C. Clavijo, Yvan Douville, Laura Findeiss, Nitin Garg, Warren Gasper, Kristina A. Giles, Philip P. Goodney, Beau M. Hawkins, Christine R. Herman, Jeffrey A. Kalish, Matthew C. Koopmann, Igor A. Laskowski, Carlos Mena-Hurtado, Raghu Motaganahalli, Vincent L. Rowe, Andres Schanzer, Peter A. Schneider, Jeffrey J. Siracuse, Maarit Venermo, Kenneth Rosenfield
Publikováno v:
New England Journal of Medicine. 387:2305-2316
Patients with chronic limb-threatening ischemia (CLTI) require revascularization to improve limb perfusion and thereby limit the risk of amputation. It is uncertain whether an initial strategy of endovascular therapy or surgical revascularization for
Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Artery Disease
Autor:
Sourbha S. Dani, Arjun Majithia, Henry Ssemaganda, Susan Robbins, Daniel J. Bertges, Jens Eldrup-Jorgensen, Art Sedrakyan, Michael Levy, Flora S. Siami, Karen E. Joynt Maddox, Michael Matheny, Eric Secemsky, Frederic Resnic
Publikováno v:
Journal of Vascular and Interventional Radiology.
Autor:
Alik Farber, Michael Strong, Susan F. Assmann, Kenneth Rosenfield, Jeffrey J. Siracuse, Flora S. Siami, Matthew T. Menard, Maria F. Villarreal
Publikováno v:
Annals of Vascular Surgery. 62:406-411
Background Although randomized controlled trials (RCTs) provide the most reliable form of scientific evidence, they are challenging to complete because of a variety of enrollment obstacles. We evaluated obstacles in a large RCT by comparing survey re
Autor:
Michael E. Farkouh, Michael Domanski, George D. Dangas, Lucas C. Godoy, Michael J. Mack, Flora S. Siami, Taye H. Hamza, Binita Shah, Giulio G. Stefanini, Mandeep S. Sidhu, Jean-François Tanguay, Krishnan Ramanathan, Samin K. Sharma, John French, Whady Hueb, David J. Cohen, Valentin Fuster, Tanim N. Zazif, Hoang Thai, Jeffrey R Burton, Erick Schampaert, Jorge Escobedo, Jean-Luc Dubois-Rande, Carlos Macaya, Didier Carrie, Gert Richardt, Ariel Roguin, Chaim Lotan, Ran Kornowski, Patrizia Presbitero, J. Eduardo Sousa, Jorge G. Velásquez, Alfredo Rodriguez, Gerry Devlin, John K. French, Upendra Kaul
Publikováno v:
Journal of the American College of Cardiology. 73:629-638
Background The FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for patients with diabetes mellitus (DM) and multivessel coronary disease (MVD), corona
Autor:
William E. Boden, Helen Vlachos, Vera Bittner, Michael E. Farkouh, Pamela M. Hartigan, Flora S. Siami, G.B. John Mancini, Robert L. Frye, Maria M. Brooks, Valentin Fuster, Mandeep S. Sidhu, Bernard R. Chaitman
Publikováno v:
Journal of the American College of Cardiology. 73:400-411
Background The optimal coronary revascularization strategy in patients with stable ischemic heart disease (SIHD) who have type 2 diabetes (T2DM) and chronic kidney disease (CKD) remains unclear. Objectives This patient-level pooled analysis sought to
Autor:
Elodie Baumfeld Andre, Nate Carrington, Flora S. Siami, Jo Carol Hiatt, Carly McWilliams, Carolyn Hiller, Andy Surinach, Alejandro Zamorano, Chris L. Pashos, Wade L. Schulz
Publikováno v:
Clinical pharmacology and therapeutics. 112(6)
Real-world data (RWD) and real-world evidence (RWE) are becoming essential tools for informing regulatory decision making in health care and offer an opportunity for all stakeholders in the healthcare ecosystem to evaluate medical products throughout
Autor:
Valentin Fuster, G.B. John Mancini, Maria M. Brooks, Lucas C. Godoy, Robert L. Frye, Vera Bittner, Flora S. Siami, Helen Vlachos, Pamela M. Hartigan, Michael E. Farkouh, William E. Boden, Bernard R. Chaitman
Publikováno v:
Journal of the American College of Cardiology. 76(19)
Elevated low-density lipoprotein cholesterol (LDL-C) is associated with increased cardiovascular events, especially in high-risk populations.This study sought to evaluate the influence of LDL-C on the incidence of cardiovascular events either followi
Autor:
Flora S. Siami, Rodrigo Barbosa Esper, Lucas C. Godoy, Whady Hueb, Michael E. Farkouh, Valentin Fuster, John K. French, Expedito E. Ribeiro, Michael J. Domanski, Verghese Mathew, Taye H. Hamza
Publikováno v:
Journal of the American College of Cardiology. 72:2826-2837
Background Diabetes mellitus (DM) is associated with complex coronary artery disease (CAD), which in turn results in increased morbidity and mortality from cardiovascular disease. Objectives This study sought to evaluate the utility of SYNTAX score (
Publikováno v:
International journal of cardiology. 293
The incidence and prognostic significance of acute kidney injury (AKI) in patients with diabetes mellitus and multivessel coronary artery disease undergoing coronary revascularization is not well known. The current analysis included patients randomiz
Autor:
Michael E, Farkouh, Michael, Domanski, George D, Dangas, Lucas C, Godoy, Michael J, Mack, Flora S, Siami, Taye H, Hamza, Binita, Shah, Giulio G, Stefanini, Mandeep S, Sidhu, Jean-François, Tanguay, Krishnan, Ramanathan, Samin K, Sharma, John, French, Whady, Hueb, David J, Cohen, Valentin, Fuster, Upendra, Kaul
Publikováno v:
Journal of the American College of Cardiology. 73(6)
The FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for patients with diabetes mellitus (DM) and multivessel coronary disease (MVD), coronary artery b